• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物抑制 HIF2 可预防雌激素缺乏模型动物的骨丢失。

Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency.

机构信息

Department of Orthopaedic Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104.

Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.

出版信息

Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2416004121. doi: 10.1073/pnas.2416004121. Epub 2024 Nov 27.

DOI:10.1073/pnas.2416004121
PMID:39602268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11626196/
Abstract

Estrogen deficiency, which is linked to various pathological conditions such as primary ovarian insufficiency and postmenopausal osteoporosis, disrupts the delicate balance between bone formation and resorption. This imbalance leads to bone loss and an increased risk of fractures, primarily due to a significant reduction in trabecular bone mass. Trabecular osteoblasts, the cells responsible for bone formation within the trabecular compartment, originate from skeletal progenitors located in the bone marrow. The microenvironment of the bone marrow contains hypoxic (low oxygen) regions, and the hypoxia-inducible factor-2α (HIF2) plays a crucial role in cellular responses to these low-oxygen conditions. This study demonstrates that the loss of HIF2 in skeletal progenitors and their derivatives during development enhances trabecular bone mass by promoting bone formation. More importantly, PT2399, a small molecule that specifically inhibits HIF2, effectively prevents trabecular bone loss in ovariectomized adult mice, a model for estrogen-deficient bone loss. Both the genetic and pharmacological approaches result in an increase in osteoblast number, which is linked to the expansion of the pool of skeletal progenitor cells. This expansion either by loss or inhibition of HIF2 uncovers a pivotal mechanism for increasing osteoblast numbers and bone formation, resulting in greater trabecular bone mass.

摘要

雌激素缺乏与多种病理状况有关,如原发性卵巢功能不全和绝经后骨质疏松症,破坏了骨形成和吸收之间的微妙平衡。这种失衡导致骨丢失和骨折风险增加,主要是由于小梁骨量的显著减少。小梁成骨细胞是负责小梁骨形成的细胞,起源于位于骨髓中的骨骼祖细胞。骨髓的微环境包含缺氧(低氧)区域,缺氧诱导因子-2α(HIF2)在细胞对这些低氧条件的反应中起着至关重要的作用。这项研究表明,在发育过程中,骨骼祖细胞及其衍生物中 HIF2 的缺失通过促进骨形成增强了小梁骨量。更重要的是,小分子化合物 PT2399 特异性抑制 HIF2,可有效防止去卵巢成年小鼠(雌激素缺乏性骨丢失模型)的小梁骨丢失。基因敲除和药理学方法都导致成骨细胞数量增加,这与骨骼祖细胞池的扩大有关。通过 HIF2 的缺失或抑制来扩大骨骼祖细胞池,揭示了增加成骨细胞数量和骨形成的关键机制,从而导致小梁骨量增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/162666f8abf5/pnas.2416004121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/81cc0aee4da0/pnas.2416004121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/d837c944f03d/pnas.2416004121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/6e644c6cc7de/pnas.2416004121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/f3029c2d67e5/pnas.2416004121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/a171bd801661/pnas.2416004121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/9b1f28d1dd09/pnas.2416004121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/162666f8abf5/pnas.2416004121fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/81cc0aee4da0/pnas.2416004121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/d837c944f03d/pnas.2416004121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/6e644c6cc7de/pnas.2416004121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/f3029c2d67e5/pnas.2416004121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/a171bd801661/pnas.2416004121fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/9b1f28d1dd09/pnas.2416004121fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdac/11626196/162666f8abf5/pnas.2416004121fig07.jpg

相似文献

1
Pharmacological inhibition of HIF2 protects against bone loss in an experimental model of estrogen deficiency.药物抑制 HIF2 可预防雌激素缺乏模型动物的骨丢失。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2416004121. doi: 10.1073/pnas.2416004121. Epub 2024 Nov 27.
2
Lycopene influences osteoblast functional activity and prevents femur bone loss in female rats submitted to an experimental model of osteoporosis.番茄红素影响成骨细胞的功能活性,并防止去卵巢骨质疏松症大鼠模型的股骨骨质丢失。
J Bone Miner Metab. 2019 Jul;37(4):658-667. doi: 10.1007/s00774-018-0970-8. Epub 2018 Oct 24.
3
A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.一种新型瑞香素衍生物可调节骨形成和骨吸收,改善雌激素依赖性骨丢失。
J Bone Miner Res. 2019 Feb;34(2):361-374. doi: 10.1002/jbmr.3604. Epub 2018 Nov 5.
4
Selective Pyk2 inhibition enhances bone restoration through SCARA5-mediated bone marrow remodeling in ovariectomized mice.选择性 Pyk2 抑制通过 SCARA5 介导的骨髓重构增强去卵巢小鼠的骨修复。
Cell Commun Signal. 2024 Nov 22;22(1):561. doi: 10.1186/s12964-024-01945-8.
5
Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.压电微振动减轻雌激素缺乏引起的骨质疏松症,并促进成骨细胞中的 Piezo1、miR-29a 和 Wnt3a 信号。
Int J Mol Sci. 2021 Aug 31;22(17):9476. doi: 10.3390/ijms22179476.
6
11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.11β-HSD1 在与全身糖皮质激素治疗相关的小梁骨丢失中发挥关键作用。
Arthritis Res Ther. 2019 Aug 16;21(1):188. doi: 10.1186/s13075-019-1972-1.
7
Antibody-based inhibition of circulating DLK1 protects from estrogen deficiency-induced bone loss in mice.抗体抑制循环性 DLK1 可防止小鼠雌激素缺乏引起的骨质流失。
Bone. 2018 May;110:312-320. doi: 10.1016/j.bone.2018.02.030. Epub 2018 Feb 27.
8
Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.从印度黄檀心材中分离得到的快速长效新黄酮类化合物dalbergin 是治疗骨质疏松症的有效药物:Dalbergin 的骨保护作用。
Biomed Pharmacother. 2016 Oct;83:942-957. doi: 10.1016/j.biopha.2016.08.010. Epub 2016 Aug 11.
9
Hydroxyurea blunts mitochondrial energy metabolism and osteoblast and osteoclast differentiation exacerbating trabecular bone loss in sickle cell mice.羟基脲会削弱线粒体能量代谢以及成骨细胞和破骨细胞的分化,加剧镰状细胞病小鼠的小梁骨丢失。
Cell Death Dis. 2024 Dec 18;15(12):907. doi: 10.1038/s41419-024-07296-z.
10
Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.雌激素缺乏和细胞衰老在骨质疏松症发病机制中的独立作用:在年轻成年小鼠和老年人类中的证据。
J Bone Miner Res. 2019 Aug;34(8):1407-1418. doi: 10.1002/jbmr.3729. Epub 2019 Jun 21.

引用本文的文献

1
Emerging regulated cell death mechanisms in bone remodeling: decoding ferroptosis, cuproptosis, disulfidptosis, and PANoptosis as therapeutic targets for skeletal disorders.骨重塑中新兴的程序性细胞死亡机制:将铁死亡、铜死亡、二硫死亡和PAN凋亡解码为骨骼疾病的治疗靶点
Cell Death Discov. 2025 Jul 21;11(1):335. doi: 10.1038/s41420-025-02633-3.

本文引用的文献

1
Osteoblastic erythropoietin is not required for bone mass accrual.骨量增加不需要成骨细胞促红细胞生成素。
JBMR Plus. 2024 Apr 15;8(6):ziae052. doi: 10.1093/jbmrpl/ziae052. eCollection 2024 Jun.
2
Skeletal stem and progenitor cells in bone development and repair.骨骼中的干细胞和祖细胞在骨骼发育和修复中的作用。
J Bone Miner Res. 2024 Jul 23;39(6):633-654. doi: 10.1093/jbmr/zjae069.
3
Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis.早发性卵巢功能不全/早绝经女性的骨骼健康:23 年的纵向分析。
Hum Reprod. 2024 May 2;39(5):1013-1022. doi: 10.1093/humrep/deae037.
4
Radiation-induced bone loss in mice is ameliorated by inhibition of HIF-2α in skeletal progenitor cells.辐射诱导的小鼠骨丢失通过抑制成骨祖细胞中的 HIF-2α得到改善。
Sci Transl Med. 2023 Nov 29;15(724):eabo5217. doi: 10.1126/scitranslmed.abo5217.
5
SIRT2 regulates extracellular vesicle-mediated liver-bone communication.SIRT2 调节细胞外囊泡介导的肝骨通讯。
Nat Metab. 2023 May;5(5):821-841. doi: 10.1038/s42255-023-00803-0. Epub 2023 May 15.
6
Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis.骨髓内膜干细胞决定活跃的成骨作用和侵袭性的肿瘤发生。
Nat Commun. 2023 Apr 25;14(1):2383. doi: 10.1038/s41467-023-38034-2.
7
Degradation-Resistant Hypoxia Inducible Factor-2α in Murine Osteocytes Promotes a High Bone Mass Phenotype.小鼠骨细胞中抗降解的缺氧诱导因子-2α促进高骨量表型。
JBMR Plus. 2023 Feb 17;7(4):e10724. doi: 10.1002/jbm4.10724. eCollection 2023 Apr.
8
Bone marrow and periosteal skeletal stem/progenitor cells make distinct contributions to bone maintenance and repair.骨髓和骨膜骨骼干细胞/祖细胞对骨骼维持和修复有不同的贡献。
Cell Stem Cell. 2022 Nov 3;29(11):1547-1561.e6. doi: 10.1016/j.stem.2022.10.002. Epub 2022 Oct 21.
9
New insights into the role of matrix metalloproteinase 3 (MMP3) in bone.基质金属蛋白酶3(MMP3)在骨骼中作用的新见解。
FASEB Bioadv. 2022 Jun 15;4(8):524-538. doi: 10.1096/fba.2021-00092. eCollection 2022 Aug.
10
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.贝伐珠单抗治疗 von Hippel-Lindau 病相关肾细胞癌
N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425.